New COVID-19 Variant Evades Vaccines
The US Centers for Disease Control and Prevention (CDC) has issued a warning regarding a new mutation of the virus responsible for the COVID-19 pandemic, known as the FLiRT variants
After China announced encouraging results with the drug Favipiravir, in the fight against the coronavirus, the spotlight turned to it. What do we know about this medicine so far?
Favipiravir was developed by the Japanese corporation as an anti-influenza agent. In February, clinical trials began in Wuhan and Shenzhen's Chinese cities for its effectiveness against the coronavirus COVID-19 infection, and on March 17, Beijing announced positive results.
“It has a high degree of safety and is clearly effective in treatment,” Zhang Xinmin, an official at China’s science and technology ministry, told reporters on Tuesday.
The study involved 340 patients.
In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug, The Guardian reported.
However, the company which manufactures the drug (Fujifilm Toyama Chemical also known as Avigan), has declined to comment on the claims.
Another well-known drug currently being tested for coronavirus infection is Remdesivir, which was developed for Ebola. If one of the two drugs passes all the necessary clinical tests and is marketed, it could halt the pandemic while we wait for a reliable vaccine.
The new coronavirus has claimed the lives of more than 8,000 people worldwide since it appeared in December.
We need your support so Novinite.com can keep delivering news and information about Bulgaria! Thank you!
Stylists recommend that you pay attention to the acidity of hair cosmetics, since this indicator affects the product's effectiveness.
WHO/Europe report warns of lethal levels of salt consumption and uncontrolled high blood pressure
Pediatric heart surgeries in Bulgaria have been temporarily halted due to a critical shortage of nurses
The US Centers for Disease Control and Prevention (CDC) has issued a warning regarding a new mutation of the virus responsible for the COVID-19 pandemic, known as the FLiRT variants
In response to the threat of a whooping cough epidemic, Bulgaria has enacted temporary anti-epidemic measures aimed at curbing the spread of the disease
Bulgaria has updated its immunization calendar, granting general practitioners the authority to administer whooping cough (pertussis) vaccines to newborns two weeks earlier than before, starting at six weeks after birth
Sofia Airport's Terminal 3 Construction Set to Begin in Early 2026
COVID-19 Impact: Bulgaria's Grim Milestone as Highest Death Rate in EU